RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medipharm Labs Stock

Medipharm Labs Debt 2024

Medipharm Labs Debt

-15.69 CAD

Ticker

LABS.TO

ISIN

CA58504D1006

WKN

A2N7AA

In 2024, Medipharm Labs's total debt was -15.69 CAD, a -33.25% change from the -23.5 CAD total debt recorded in the previous year.

Medipharm Labs Aktienanalyse

What does Medipharm Labs do?

MediPharm Labs Corp is a leading company in the cannabis industry, specializing in the production of specialized, high-quality cannabis products. The company was founded in 2015 by founders Pat McCutcheon and Keith Strachan and is headquartered in Barrie, Ontario, Canada. Medipharm Labs ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Medipharm Labs's Debt Structure

Medipharm Labs's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Medipharm Labs's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Medipharm Labs’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Medipharm Labs’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Medipharm Labs stock

What is the debt of Medipharm Labs this year?

Medipharm Labs has a debt level of -15.69 CAD this year.

What was the debt of Medipharm Labs compared to the previous year?

The debt of Medipharm Labs has increased by -33.25% compared to the previous year dropped.

What are the consequences of high debt for investors in Medipharm Labs?

High debt can pose a risk for investors of Medipharm Labs, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Medipharm Labs?

Low debt means that Medipharm Labs has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Medipharm Labs affect the company?

An increase in debt of Medipharm Labs can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Medipharm Labs affect the company?

A reduction in debt of Medipharm Labs can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Medipharm Labs?

Some factors that can influence the debt of Medipharm Labs include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Medipharm Labs so important for investors?

The debts of Medipharm Labs are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Medipharm Labs take to change the debt?

To change the debt, Medipharm Labs can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Medipharm Labs pay?

Over the past 12 months, Medipharm Labs paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medipharm Labs is expected to pay a dividend of 0 CAD.

What is the dividend yield of Medipharm Labs?

The current dividend yield of Medipharm Labs is .

When does Medipharm Labs pay dividends?

Medipharm Labs pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medipharm Labs?

Medipharm Labs paid dividends every year for the past 0 years.

What is the dividend of Medipharm Labs?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medipharm Labs located?

Medipharm Labs is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medipharm Labs kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medipharm Labs from 12/12/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did Medipharm Labs pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of Medipharm Labs in the year 2023?

In the year 2023, Medipharm Labs distributed 0 CAD as dividends.

In which currency does Medipharm Labs pay out the dividend?

The dividends of Medipharm Labs are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medipharm Labs

Our stock analysis for Medipharm Labs Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medipharm Labs Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.